Noetik, a Bay Area startup founded by former Recursion executives, has successfully raised an oversubscribed $40 million in a Series A funding round. The funding will be used to advance Noetik's clinical translation AI models for cancer treatment. The round was led by Amy Schulman from Polaris Partners, providing significant validation for Noetik's platform.